ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628560 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628560; 2) Community: the network communities that were significantly associated with the response to NSC 628560; 3) Molecule: the relationships between components within communities and NSC 628560; 4) MDR: the compounds that were significantly associated with the NSC 628560.

NSC Compound Enrichment Correlation
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.0352383000003052 0.0092241824
NSC 100880 Camptothecin 0.0352383000003056 0.10064955
NSC 114346 Null 0.0352383000003056 0.38194392
NSC 132313 Dianhydrogalactitol 0.0352383000003056 0.1424142
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0352383000003056 0.24381784
NSC 18805 .gamma.-Thujaplicine 0.0352383000003056 0.10415307
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0352383000003056 0.44157424
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0352383000003056 0.30695759
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0352383000003056 0.46157418
NSC 339137 PHYSALOLACTONE 0.0352383000003056 0.47489144
Total:136  Current:101    [First] [Prev] [Next] [Last]